|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 冠状动脉钙化用于指导个性化阿司匹林治疗以预防心血管病:基于多民族动脉粥样硬化研究显示文摘最近美国心脏病学会/美国心脏协会(American College of Cardiology/American Heart Association,ACC/AHA)的一级预防指南建议,低剂量阿司匹林治疗仅适用于年龄40~70岁、患动脉粥样硬化性心血管病(atherosclerotic cardiovascular disease,ASCVD)风险较高,但出血风险不高的成年人。然而,尚不清楚如何更准确地识别出这些患者。根据2019年降低心血管病相对危险度和出血风险的阿司匹林荟萃分析研究数据,本研究旨在评估冠状动脉钙化(coronary artery calcium,CAC)在指导阿司匹林在一级预防中如何使用的价值。 | 周卫(译) 叶鹏(摘/审校) Achirica MC Miedema MD McEvoy JW Rifai MA Greenland P Dardari Z Budoff M Blumenthal RS Yeboah J Duprez DA Mortensen MB Dzaye O Hong J Nasir K Blaha MJ | 2020 | 中华高血压杂志2020，28，4： | 2 |
| 2 | Plasma folate, vitamin B6, vitamin B12, and homo- cysteine and pancreatic cancer risk in four large cohorts显示文摘 | Schernhammer E Wolpin B Rifai N Cochrane B Manson J A Ma J | 2007 | Cancer Res2007，67，： | 1 |
| 3 | Long-term effects of pravastatin on plasma concentration of C-reactive protein显示文摘 | Ridker PM Rifai N Pfeffer MA | 1999 | Circulation1999，100，： | 1 |
| 4 | Effect of statin therapy on C reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study显示文摘 | Albert MA Danielson E Rifai N | 2001 | JAMA2001，286，1： | 1 |
| 5 | Effect of statin therapy on creative protein levels: the pravastatin inflammation/CRP evaluation (PRINE): a randomizen trial and cohort study 显示文摘 | Albert MA Danielson E Rifai N | 2001 | JAMA2001，286，： | 1 |
| 6 | Long term effects of pravastatin on plasma concentration of C-reactive protein显示文摘 | Ridker PM Rifai N Pfeffer MA | 1999 | Circulation1999，100，： | 1 |
| 7 | Apolipoprotein (a) size and lipo- protein (a) concerntration and future risk angine pectoris with evi- dence of severe coronary atheroselerosis in men: the physicians, health study 显示文摘 | Rifai N Ma J Sacks FM | 2004 | Clin Chem2004，50，： | 1 |
| 8 | Effect of statin ther-apy on C-reactive protein levels : the pravastatin inflamma-tion/ CRP evaluation ( PRINCE) :a randomized trial and co-hort study 显示文摘 | Albert MA Danielson E Rifai N | 2001 | JAMA2001，286，1： | 1 |
| 9 | Inflammation,pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels显示文摘 | Rifai N Pfeifer MA | 1998 | Circulation1998，98，： | 1 |
| 10 | Prospective study of Creactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death显示文摘 | Albert CM Ma J Rifai N | 2002 | Circulation2002，，105： | 1 |
| 11 | Long-term effects of pravastatin on plasma concentration of C-reactive protein:The Cholesterol and Recurrent Events(CARE) Investigators显示文摘 | Ridker PM Rifai N Preffer MA | 1999 | Circulation1999，100，： | 1 |
| 12 | Prospective study of C-reactive protein, homocysteine and plasma lipid levels as predictor of sudden cardiac deat h显示文摘 | Albert CM Ma J Rifai N | 2002 | Circulation2002，105，22： | 1 |
| 13 | Effect of statinstherapy on creactive protein levels:the pravastatininfammatory/CRP evaluation(PRNCE):a randomized trial and cohort study显示文摘 | Albert MA Danielson E Rifai N | 2001 | JAMA2001，286，1： | 1 |
| 14 | Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study显示文摘 | Albert MA Danielson E Rifai N | 2001 | JAMA2001，286，1： | 1 |
| 15 | Inflammation,pravatatin,and the risk of coronary events after myocardial infarction in patients with average cholesterol levels:Cholesterol and recurrent events(CARE) investigators显示文摘 | Ridker PM Rifai N Pfeffer MA | 1998 | Circulation1998，98，： | 1 |
| 16 | Long - term effects of pravastatin on plasma concentration of C - reactive protein 显示文摘 | Ridker PM Rifai N Pfeffer MA | 1999 | Circulation1999，100，： | 1 |
| 17 | Effect of statin therapy on C-reactive protein levels:the pravastatin inflammation/CRP evaluation (PRINCE):a randomized trial and cohort study显示文摘 | Albert MA Danielson E Rifai N | 2001 | JAMA2001，286，1： | 1 |
| 18 | Prospective study of C-reactive protein,homocysteine,and plasma lipid levels as predictors of sudden cardiac death显示文摘 | Albert CM Ma J Rifai N | 2002 | Circulation2002，105，22： | 1 |
| 19 | Effect of therapy on C-Reactive protein level:The pravastatin inflammation/CRP evaluation (PRINCE):a randonavzed triavl and cohort study显示文摘 | Albert MA Daninelson E Rifai N | 2001 | TAMA2001，286，1： | 1 |
| 20 | The Cholesterol and recurrent events (CARE) in-vestigators显示文摘 | Ridker PM Rifai N Pfeffer MA Long-term ef-fects of pravastatin on plasma concentration of C-reactiveprotein | 1999 | Circulation1999，100，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员